Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16820555rdf:typepubmed:Citationlld:pubmed
pubmed-article:16820555lifeskim:mentionsumls-concept:C0004238lld:lifeskim
pubmed-article:16820555lifeskim:mentionsumls-concept:C0001563lld:lifeskim
pubmed-article:16820555lifeskim:mentionsumls-concept:C0025859lld:lifeskim
pubmed-article:16820555lifeskim:mentionsumls-concept:C0524727lld:lifeskim
pubmed-article:16820555lifeskim:mentionsumls-concept:C0013125lld:lifeskim
pubmed-article:16820555lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:16820555lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:16820555pubmed:issue1 Suppllld:pubmed
pubmed-article:16820555pubmed:dateCreated2006-7-5lld:pubmed
pubmed-article:16820555pubmed:abstractTextAtrial fibrillation (AF) is the most common arrhythmia to occur after cardiac surgery, with an incidence of 20% to 40%. AF is associated with postoperative complications, including increased risk of stroke and need of additional treatment, as well as prolonged hospital stay and increased costs. It has been shown that prophylactic oral administration of beta-blocker therapy reduces the incidence of postoperative AF after cardiac surgery. However, it is possible that absorption of drugs is impaired after cardiopulmonary perfusion associated with cardiac surgery. The purpose of this prospective, controlled, randomized trial was to study compare intravenous and per oral metoprolol administration in the prevention of AF after cardiac surgery.lld:pubmed
pubmed-article:16820555pubmed:languageenglld:pubmed
pubmed-article:16820555pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16820555pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16820555pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16820555pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16820555pubmed:statusMEDLINElld:pubmed
pubmed-article:16820555pubmed:monthJullld:pubmed
pubmed-article:16820555pubmed:issn1524-4539lld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:TurpeinenAnuAlld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:HartikainenJu...lld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:HalonenPirjoPlld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:HakalaTapioTlld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:HippeläinenMi...lld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:UusaroAriAlld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:HalonenJariJlld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:AuvinenTommiTlld:pubmed
pubmed-article:16820555pubmed:authorpubmed-author:KarjalainenJa...lld:pubmed
pubmed-article:16820555pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16820555pubmed:day4lld:pubmed
pubmed-article:16820555pubmed:volume114lld:pubmed
pubmed-article:16820555pubmed:ownerNLMlld:pubmed
pubmed-article:16820555pubmed:authorsCompleteYlld:pubmed
pubmed-article:16820555pubmed:paginationI1-4lld:pubmed
pubmed-article:16820555pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:meshHeadingpubmed-meshheading:16820555...lld:pubmed
pubmed-article:16820555pubmed:year2006lld:pubmed
pubmed-article:16820555pubmed:articleTitleIntravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery.lld:pubmed
pubmed-article:16820555pubmed:affiliationDepartment of Surgery, Kuopio University Hospital, PO Box 1777, FIN-70211 Kuopio, Finland. jari.halonen@kuh.filld:pubmed
pubmed-article:16820555pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16820555pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16820555pubmed:publicationTypeRandomized Controlled Triallld:pubmed